Ahmet Sarıcı
Ahmet Sarıcı publishes mostly in Hematology, Genetics and Oncology, on topics such as Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments and Hemoglobinopathies and Related Disorders.
- World rank
- #7,597,391 of 7,710,434 ranked researchers
- Rank in Türkiye
- #113,204 of 117,622
- Works
- 80
- Citations
- 285
- Citations per work
- 3.6
What does Ahmet Sarıcı research?
Ahmet Sarıcı's work is mostly in Medicine (53%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4253.1%
- Medicine4253.1%
- Everything else3442.9%
- Life Sciences34.0%
- 1Hematology25% of their works
- 2Genetics9% of their works
- 3Oncology8% of their works
- 4Infectious Diseases6% of their works
- 5Epidemiology4% of their works
- 6Immunology4% of their works
Research topics
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Hemoglobinopathies and Related Disorders
- COVID-19 Clinical Research Studies
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
Which keywords describe Ahmet Sarıcı's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Bone Marrow Niche, Graft-versus-Host Disease, Epidemiology, Diagnosis Criteria, International Myeloma Working Group, Rituximab and Prognostic Factors.
- Myelofibrosis
- Acute Myeloid Leukemia
- Lymphoma
- Classification
- SARS-CoV-2
- Thalassemia
- Prognostic Factors
- International Myeloma Working Group
- Epidemiology
- Bone Marrow Niche
- Hematopoietic Stem Cells
- Graft-versus-Host Disease
- Diagnosis Criteria
- Rituximab
- Sickle-cell Disease
- Clinical Characteristics
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- AML
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Hematopoietic Stem Cells252 topics
- Bone Marrow Niche201 topic
- Graft-versus-Host Disease201 topic
- Epidemiology152 topics
- Diagnosis Criteria131 topic
- International Myeloma Working Group131 topic
- Rituximab122 topics
- Prognostic Factors112 topics
- Sickle-cell Disease81 topic
- Thalassemia81 topic
- Clinical Characteristics71 topic
- SARS-CoV-271 topic
- Chronic Lymphocytic Leukemia61 topic
- Classification61 topic
- Genomic Aberrations61 topic
- Lymphoma61 topic
- AML51 topic
- Acute Myeloid Leukemia51 topic
- JAK2 Mutation51 topic
- Myelofibrosis51 topic
Where does Ahmet Sarıcı work?
Ahmet Sarıcı's main affiliation in the publication record is Inonu University, Türkiye.
How many publications and citations does Ahmet Sarıcı have?
OpenAlex counts 80 works and 285 citations for Ahmet Sarıcı, an h-index of 7, ranking #7,597,391 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ahmet Sarıcı. Posts are plain text and can be reported.